Cuorips (TSE:4894) NonCurrent Deferred Liabilities: 円 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4894 Cuorips Inc TSE:4894
75 GF Score
Price 円5,820.00
GF Value 円6,226.26
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Cuorips NonCurrent Deferred Liabilities?

Cuorips TSE:4894 +0.69% 75 NonCurrent Deferred Liabilities is 円 Mil as of Jun. 2026. GuruFocus rates TSE:4894 with a GF Score™ of 75/100 and a GF Value™ of 円6,226.26 (Fairly Valued). The stock has 2 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Cuorips's non-current deferred liabilities for the quarter that ended in Jun. 2026 was 円 Mil.

Cuorips NonCurrent Deferred Liabilities Related Terms

Cuorips NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Cuorips's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cuorips NonCurrent Deferred Liabilities Chart

Cuorips Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial - - - - -

Cuorips Quarterly Data
Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -
TSE:4894
75GF Score
Cuorips Inc TSE:4894
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of 円 Mil mean?
Cuorips (TSE:4894) has a NonCurrent Deferred Liabilities of 円 Mil as of Jun. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Cuorips and its competitors.
Is Cuorips' NonCurrent Deferred Liabilities too high?
Cuorips' current NonCurrent Deferred Liabilities is 円 Mil. Overall, Cuorips has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cuorips' NonCurrent Deferred Liabilities compare to VRTX and REGN?
Cuorips' NonCurrent Deferred Liabilities of 円 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Biotechnology company?
A good NonCurrent Deferred Liabilities depends on the Biotechnology industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Cuorips and its competitors. Cuorips's current NonCurrent Deferred Liabilities is 円 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cuorips stock overvalued right now?
Based on GuruFocus' analysis, Cuorips (TSE:4894) is currently considered Fairly Valued. The stock's GF Value™ is 円6,226.26, compared to a current price of 円5,820.00 — trading 6.5% below its estimated fair value. The current NonCurrent Deferred Liabilities is 円 Mil. Cuorips' overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Cuorips (TSE:4894), the current NonCurrent Deferred Liabilities is 円 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cuorips (TSE:4894) Overvalued in 2026?

Based on GuruFocus' analysis, Cuorips stock appears to be undervalued. The current stock price of 円5,820.00 is trading 6.5% below its estimated GF Value™ of 円6,226.26. GuruFocus considers Cuorips to be Fairly Valued.

Key valuation signals for TSE:4894:

  • NonCurrent Deferred Liabilities: 円 Mil
  • GF Value™: 円6,226.26 vs. price of 円5,820.00 (6.5% below fair value)
  • GF Score™: 75/100 with 2 warning signs

No single metric tells the full story. See the TSE:4894 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cuorips Business Description

Address 3-11-5 Nihonbashi-Honcho, 507, Nihonbashi Life Science Building 2, Chuo-ku, Tokyo, JPN, 103-0023
Cuorips Inc is engaged in the Research, development, manufacturing, and sales of Cellular and Tissue-based Products and Cell processing products. The company is also engaged in Contract development and manufacturing services and consulting services of Cellular and Tissue-based Products and Cell processing product.
75GF Score

Get the complete analysis for TSE:4894

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円5,820.00
Price
円6,226.26
GF Value